Intrust Bank
TGTX icon

Intrust Bank’s TG Therapeutics TGTX Stock Holding History

Intrust Bank’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$222K Buy
+3,977
New +$215K 0.02% 393

Other funds holding TGTX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Intrust Bank's TGTX Position: Q3 2026 in Review

Intrust Bank opened a new position in TG Therapeutics (TGTX) in Q3 2026: 3,977 shares worth $222K. The stake represents 0.02% of the portfolio and ranks #393 among its holdings.

311 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Intrust Bank held 3,977 shares of TG Therapeutics worth $222K as of Q3 2026.
  • TG Therapeutics was a new Intrust Bank position in Q3 2026.
  • TG Therapeutics made up 0.02% of Intrust Bank's portfolio in Q3 2026, its #393 holding.
  • 311 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Intrust Bank's 13F filing for Q3 2026, filed 13 Nov 2026.